Core Insights - The article highlights the top-performing analysts in the U.S. for the year 2025, as ranked by TipRanks based on their success rates and average returns [1][2]. Analyst Rankings - **Sam Slutsky – LifeSci Capital**: Achieved the highest ranking with a success rate of 67.74% and an average return of 62.4%. His notable recommendation on Abivax SA (ABVX) yielded a return of 894.81% [3]. - **Richard Shannon – Craig-Hallum**: Ranked second with a success rate of 61.87% and an average return of 36.9%. His top call on Aeva Technologies (AEVA) generated a return of 822.14% [4]. - **Joseph Stringer – Needham**: Secured the third position with a success rate of 79.17% and an average return of 38.2%. His best recommendation was for Inozyme Pharma (INZY), which returned 361.9% [5]. - **Myles Minter – William Blair**: Fourth place with a success rate of 66.93% and an average return of 28.8%. His top recommendation on Ovid Therapeutics (OVID) yielded a profit of 350% [6]. - **Ruben Roy – Stifel Nicolaus**: Fifth on the list with a success rate of 75.68% and an average return of 35.3%. His best call on CoreWeave (CRWV) generated a return of 293.2% [7]. - **Seamus Fernandez – Guggenheim**: Ranked sixth with a success rate of 78.57% and an average return of 40.6%. His best recommendation was for Cidara Therapeutics (CDTX), which returned 244.7% [8]. - **Thomas Smith – Leerink Partners**: Seventh place with an average return of 30.7% and a success rate of 65.22%. His best recommendation on Abivax yielded a return of 880.34% [9]. - **Mark Miller – Benchmark Co.**: Eighth with a success rate of 59.8% and an average return of 11.1%. His top call on SanDisk (SNDK) generated a return of 470.6% [11]. - **Allison Bratzel – Piper Sandler**: Ninth position with a success rate of 63.64% and an average return of 58.2%. His recommendation for Abivax also yielded a return of 894.81% [12]. - **Julian Harrison – BTIG**: Tenth with a success rate of 59.38% and an average return of 37%. His top recommendation on Abivax generated a return of 1,057.12% [13].

Market Overview - U.S. stock futures are lower, with Dow futures dropping approximately 700 points [1] Company-Specific Developments - Valneva SE has withdrawn its IXCHIQ Chikungunya vaccine BLA and IND in the U.S. following an FDA suspension and a review of new serious adverse events, leading to a 7.7% decline in shares to $9.29 in pre-market trading [1] - Rezolve AI PLC shares fell 15% to $3.92 in pre-market trading [2] - POET Technologies Inc experienced an 11.2% decline to $7.37 in pre-market trading [2] - Forward Industries Inc shares decreased by 10.5% to $7.70 after a previous gain of 4% on Friday [2] - Babcock & Wilcox Enterprises Inc shares dipped 9.9% to $7.59 in pre-market trading [2] - Bakkt Holdings Inc fell 9.5% to $19.38 after a 10% increase on Friday [2] - Applovin Corp shares decreased by 9.5% to $515.03 after a 6% decline on Friday [2] - ALT5 Sigma Corp shares fell 8.9% to $2.36 after gaining 7% on Friday, despite regaining Nasdaq compliance [2] - HIVE Digital Technologies Ltd shares dropped 7.7% to $3.20 in pre-market trading [2] - Aeva Technologies Inc shares declined 6.8% to $18.01 in pre-market trading [2] - Bitdeer Technologies Group fell 6.8% to $14.75 in pre-market trading [2] - Terrestrial Energy Inc shares decreased by 6.3% to $10.95 in pre-market trading [2] - Tesla Inc shares fell 2.7% to $425.75, with CEO Elon Musk confirming that vehicles equipped with the AI4 (HW4) chip will achieve unsupervised autonomous driving without upgrades [2] - NVIDIA Corp shares declined 2.4% to $181.77 in pre-market trading [2]

Aeva Technologies, Inc. (NASDAQ:AEVA) is a pioneer in the field of advanced sensing and perception systems, primarily for autonomous vehicles. The company's cutting-edge 4D LiDAR technology is setting new standards in the autonomous driving industry. Despite operating in a highly competitive market, Aeva continues to make strides in innovation and technology development.On January 15, 2026, Sinha Saurabh, the Chief Financial Officer of Aeva, made a notable transaction by selling 31,600 shares at an approxim ...

Core Insights - Aeva Technologies, a LiDAR-on-chip innovator, reported a significant insider sale by CEO Soroush Salehian Dardashti, who sold 488,160 shares for approximately $6.3 million on January 2, 2026 [1][4] - The sale represents Dardashti's largest single direct sale to date, exceeding his historical median sell size and indicating a high cadence of selling activity [7] Transaction Summary - Shares sold directly: 488,160 [2] - Total transaction value: $6.3 million [2] - Post-transaction direct shares: 1,831,199 [2] - Post-transaction indirect shares: 1,884,808 [2] - Post-transaction value of direct ownership: approximately $23.35 million [2] Company Overview - Aeva Technologies reported a trailing twelve months (TTM) revenue of $15.15 million and a net income loss of $156.26 million [5] - The stock price as of January 2, 2026, was $12.96, with a one-year price change of 342.54% [5] Company Snapshot - Aeva develops 4D LiDAR-on-chip products utilizing frequency modulated continuous wave (FMCW) sensing technology, serving various applications including automated driving and consumer electronics [6][8] Market Impact - Following Dardashti's sale, Aeva's stock price increased significantly, attributed to a deal with Nvidia for integrating Aeva's technology into the NVIDIA DRIVE Hyperion autonomous vehicle platform [11][12] - The stock price rose by 56% since the sale date, indicating strong market performance [9] Ownership Changes - Dardashti's sale reduced his direct holdings from 2,319,359 to 1,831,199 shares, while his indirect holdings remained unchanged [7] - The sale reflects a narrowing pool of shares available for future dispositions, as Dardashti's total holdings have declined by 64.88% since March 2025 [4]

Core Insights - U.S. stocks experienced an upward trend, with the Dow Jones index increasing by approximately 200 points on Friday [1] Company Highlights - CG Oncology Inc (NASDAQ:CGON) saw its shares rise by 21.8% to $51.05 after announcing an expedited timeline for topline data from the Phase 3 PIVOT-006 clinical trial, now expected in the first half of 2026 [1][2] - Rich Sparkle Holdings Ltd (NASDAQ:ANPA) surged 113.6% to $51.70 following a $39 million offering of 3 million ordinary shares at $13 per share [3] - NovaBay Pharmaceuticals Inc (NYSE:NBY) increased by 34.4% to $12.81 [3] - Quanterix Corp (NASDAQ:QTRX) gained 29.3% to $8.42 after naming Everett Cunningham as President and CEO, effective January 19 [3] - MoonLake Immunotherapeutics (NASDAQ:MLTX) rose 21.7% to $17.45 after receiving FDA feedback on its clinical evidence strategy for Sonelokimab in Hidradenitis Suppurativa [3] - Enliven Therapeutics Inc (NASDAQ:ELVN) increased by 21.5% to $28.24, sharing positive initial data from its Phase 1b ENABLE trial for ELVN-001 in chronic myeloid leukemia [3] - Aeva Technologies Inc (NASDAQ:AEVA) surged 21.2% to $20.47 [3] - Loandepot Inc (NYSE:LDI) rose 20.1% to $2.93 [3] - ASP Isotopes Inc (NASDAQ:ASPI) increased by 19.7% to $7.71 [3] - Allogene Therapeutics Inc (NASDAQ:ALLO) gained 19.5% to $1.78 [3] - Opendoor Technologies Inc (NASDAQ:OPEN) rose 19.2% to $7.67 following a new housing market proposal by President Donald Trump [3] - Liquidia Corp (NASDAQ:LQDA) jumped 14% to $36.22 after announcing preliminary full-year 2025 YUTREPIA net sales [3] - Vistra Corp (NYSE:VST) gained 13.1% to $170.34 after entering into 20-year power purchase agreements for zero-carbon nuclear energy to support Meta's operations [3] - Oklo Inc (NYSE:OKLO) rose 12.6% to $109.95 after announcing an agreement with Meta for a 1.2 gigawatt power campus [3] - Applied Digital Corp (NASDAQ:APLD) surged 11.8% to $35.72, reporting strong second-quarter results and advanced talks with a new hyperscaler tenant [3] - AST SpaceMobile Inc (NASDAQ:ASTS) gained 10% to $99.65 [3] - SanDisk Corp (NASDAQ:SNDK) increased by 9.6% to $366.93 [3] - Mirion Technologies Inc (NYSE:MIR) rose 9.5% to $26.56 [3] - TTM Technologies Inc (NASDAQ:TTMI) gained 9.1% to $72.94 [3] - SoundHound AI Inc (NASDAQ:SOUN) rose 8.5% to $11.96 [3] - Kratos Defense & Security Solutions Inc (NASDAQ:KTOS) gained 8.3% to $112.64, with B. Riley Securities maintaining a Buy rating and raising the price target from $105 to $128 [3]

Key Takeaways Aeva announced a CES 2026 partnership to supply its FMCW 4D LiDAR for NVIDIA DRIVE Hyperion.AEVA's LiDAR adds per-point velocity and position sensing, enhancing Hyperion's perception stack.Aeva sensors use silicon-photonics LiDAR-on-chip, enabling long-range, day-and-night performance.Aeva Technologies, Inc. (AEVA) , a leading developer of sensing solutions across automated driving, manufacturing automation, smart infrastructure, robotics, and consumer devices, announced a major strategic part ...

Group 1 - The article discusses the potential for investing in undervalued stocks that are mispriced by the market as a strategy for 2026 [1] - Stone Fox Capital is identified as a Registered Investment Advisor (RIA) based in Oklahoma, led by Mark Holder, who has extensive experience in investing and portfolio management [2] - The investing group "Out Fox The Street" offers various features including model portfolios, stock picks with identifiable catalysts, daily updates, real-time alerts, and community engagement for investors [2] Group 2 - The article emphasizes the importance of conducting personal research or consulting a financial advisor before making investment decisions [4] - It is noted that past performance does not guarantee future results, and no specific investment recommendations are provided [5]

Shares of this LiDAR company shot up after Nvidia announced it would supply detectors for its new self-driving car system. ...

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 400 points on Tuesday.The Dow traded up 0.86% to 49,397.20 while the NASDAQ gained 0.45% to 23,500.32. The S&P 500 also rose, gaining, 0.48% to 6,934.99.Check This Out: How To Earn $500 A Month From Jefferies Financial Stock Ahead Of Q4 EarningsLeading and Lagging SectorsHealth care shares gained by 2% on Tuesday.In trading on Tuesday, energy stocks dipped by 1.2%.Top HeadlineThe S&P Global services PMI declined to 52.5 i ...

Group 1: Market Overview - U.S. stocks experienced an upward trend, with the Dow Jones index increasing by over 100 points on Tuesday [1] - Microchip Technology Inc's shares rose significantly after the company revised its fiscal third-quarter revenue expectations upward [1] Group 2: Microchip Technology Inc - Microchip now anticipates third-quarter fiscal 2026 net sales of approximately $1.185 billion, surpassing its previous guidance range of $1.109 billion to $1.149 billion [2] - The stock price of Microchip Technology increased by 8.1%, reaching $72.47 on Tuesday following the announcement [2] Group 3: Other Notable Stock Movements - Alumis Inc saw a remarkable 129% increase in its stock price to $19.04 after positive trial results for envudeucitinib [3] - Aeva Technologies Inc's stock rose by 31.5% to $17.21 due to its technology being selected for NVIDIA's autonomous vehicle platform [3] - Terrestrial Energy Inc's shares increased by 26.9% to $8.87 after securing an agreement with the U.S. Department of Energy [3] - Bright Minds Biosciences Inc gained 25% to $100.00 following successful Phase 2 trial results [3] - OneStream Inc's stock rose by 25.1% to $23.00 amid reports of a potential buyout [3] - Other companies such as SanDisk Corp, Beam Therapeutics Inc, and Albemarle Corp also recorded significant stock price increases [3]